Plus, Donald Trump is set to visit the White House to meet with President Joe Biden for a symbolic meeting to signify a ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Vaxcyte (NASDAQ:PCVX) announced that the U.S. FDA cleared the VAX-31 infant Investigational New Drug application and granted ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

The webcast will be held on November 26, 2024, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver who will discuss highlights from Q3 2024 and provide a business update. To join the ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

Johnson & Johnson said its nipocalimab treatment for adults living with moderate-to-severe Sjögren's disease has received breakthrough therapy designation from the Food and Drug Administration.

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational ...

Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic ...

Hygiene and health company Essity has, for the fourth consecutive year, been designated a Diversity Leader by Financial Times.  The ranking was compiled by the research firm Statista on behalf of the ...